Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
Journal of Atherosclerosis and Thrombosis|December 21, 2025
Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific ReportAtsushi Tanaka, Kazuma Oyama, Yusuke Yakushiji, et al.
Journal of Atherosclerosis and Thrombosis|August 24, 2018
Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary SyndromeShusuke Yagi, Daisuke Kondo, Takayuki Ise, et al.
Heart and Vessels|March 16, 2013
Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 proteinTakeshi Soeki, Toshiyuki Niki, Etsuko Uematsu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 7, 2025
Experiences of diabetes stigma among adults with type 1 and type 2 diabetes: A multi-study, multi-country, secondary analysisElizabeth Holmes-Truscott, Eloise Litterbach, Uffe Søholm, et al.
European Heart Journal|July 6, 2021
STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseasesPhuong Tran Pham, Daiju Fukuda, Sachiko Nishimoto, et al.
Cardiovascular Diabetology|April 14, 2017
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Yosuke Okada, et al.
Journal of the American Heart Association|November 19, 2021
Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort StudiesHiroyasu Iso, Renzhe Cui, Iseki Takamoto, et al.
Cardiovascular Diabetology|September 14, 2016
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT studyAtsushi Tanaka, Toyoaki Murohara, Isao Taguchi, et al.
Cell Metabolism|September 3, 2009
Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistanceMitsuhisa Tabata, Tsuyoshi Kadomatsu, Shigetomo Fukuhara, et al.
Advances in Therapy|November 30, 2017
Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes MellitusShusuke Yagi, Ken-Ichi Aihara, Takeshi Kondo, et al.
Pageof 25